OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | +30.0% | 13,414 | +10.7% | 0.00% | – |
Q2 2023 | $40 | -43.7% | 12,113 | -56.0% | 0.00% | – |
Q1 2023 | $71 | +39.2% | 27,500 | 0.0% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 27,500 | 0.0% | 0.00% | – |
Q3 2022 | $51,000 | -23.9% | 27,500 | -11.7% | 0.00% | – |
Q2 2022 | $67,000 | -43.7% | 31,133 | -18.0% | 0.00% | – |
Q1 2022 | $119,000 | -2.5% | 37,961 | 0.0% | 0.00% | – |
Q4 2021 | $122,000 | -4.7% | 37,961 | 0.0% | 0.00% | – |
Q3 2021 | $128,000 | -13.5% | 37,961 | 0.0% | 0.00% | – |
Q2 2021 | $148,000 | 0.0% | 37,961 | +3.3% | 0.00% | – |
Q1 2021 | $148,000 | -89.7% | 36,748 | -80.1% | 0.00% | – |
Q2 2018 | $1,442,000 | -32.1% | 184,811 | -38.5% | 0.00% | – |
Q1 2018 | $2,124,000 | -28.2% | 300,480 | +0.3% | 0.00% | – |
Q4 2017 | $2,957,000 | -0.5% | 299,570 | -17.2% | 0.00% | -100.0% |
Q3 2017 | $2,971,000 | -18.3% | 361,640 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,637,000 | – | 361,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |